Invention Grant
- Patent Title: Substituted 3-(5-membered unsaturated heterocyclyl-1, 3-dihydro-indol-2-one's and derivatives thereof as kinase inhibitors
-
Application No.: US14500109Application Date: 2014-09-29
-
Publication No.: US09657005B2Publication Date: 2017-05-23
- Inventor: Xialing Guo , Zhen Zhu , Thomas C. Malone , Julie Wurster
- Applicant: Allergan, Inc.
- Applicant Address: US CA Irvine
- Assignee: ALLERGAN, INC.
- Current Assignee: ALLERGAN, INC.
- Current Assignee Address: US CA Irvine
- Agent Jonathan Bass
- Main IPC: C07F7/10
- IPC: C07F7/10 ; C07D405/14 ; C07D409/14 ; C07D405/04 ; C07D413/14 ; C07D417/14
Abstract:
The present invention relates to organic molecules capable of modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation.
Public/Granted literature
Information query
